US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 117.120
- +0.160+0.14%
Close Apr 23 16:00 ET
- 116.990
- -0.130-0.11%
Post 19:11 ET
10.99BMarket Cap-20193P/E (TTM)
119.910High117.060Low568.91KVolume117.500Open116.960Pre Close67.08MTurnover0.64%Turnover RatioLossP/E (Static)93.86MShares159.89052wk High12.79P/B10.49BFloat Cap55.25052wk Low--Dividend TTM89.61MShs Float181.830Historical High--Div YieldTTM2.44%Amplitude2.598Historical Low117.904Avg Price1Lot Size
About Sarepta Therapeutics Company
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Company Profile
SymbolSRPT
Company NameSarepta Therapeutics
Listing DateJun 4, 1997
Issue Price9.00
Founded1980
MarketNASDAQ
Employees1314
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address215 First Street,Suite 415
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-274-4000
Company Executives
- Name
- Position
- Salary
- Douglas S. Ingram,Esq.
- Director, President and Chief Executive Officer
- 124.94M
- Louise Rodino-Klapac
- Executive Vice President, Head of R&D and Chief Scientific Officer
- 3.94M
- Bilal Arif
- Executive Vice President and Chief Technical Operations Officer
- --
- Ian Michael Estepan
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 3.82M
- Ryan Edward Brown
- Executive Vice President, General Counsel and Corporate Secretary
- 3.73M
- Richard J. Barry
- Independent Director
- 562.35K
- Dr. Stephen L. Mayo, PhD
- Independent Director
- 538.90K
- Dr. Kathryn Jean Boor
- Independent Director
- 744.25K
- Michael Chambers
- Independent Director
- 744.92K
- Dr. Hans Wigzell, M.D.,PhD
- Independent Director
- 546.35K
- Dr. Claude Nicaise,M.D.
- Independent Director
- 553.35K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg